ENAGenomicsBoise and Vertino Labs, Hematology and Medical Oncology, Emory Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA121341Homo sapiensAnalysis of 143 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using a Custom Breast Cancer Panel and Human Cancer Panel for the DASL platform. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Overall design: Molecular Characterization of 143 primary breast carcinomas including 101 triple negative (TN: ER-, PR-, HER2-), 3 HER2-positive (HER2+: ER-, PR-, HER2+), and 39 hormone receptor-positive (HR+: ER+ and/or PR+)xref:PubMed:24143235ENAfalseHomo sapiensMolecular characterization of Georgia cohort of primary breast cancer FFPE tissues on custom breast cancer DASL panel2025-09-242014-02-11PRJNA121341GSE18539960624143235